Serveur d'exploration autour du libre accès en Belgique

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Ultrasound guided corticosteroid injection for plantar fasciitis: randomised controlled trial

Identifieur interne : 000778 ( Main/Exploration ); précédent : 000777; suivant : 000779

Ultrasound guided corticosteroid injection for plantar fasciitis: randomised controlled trial

Auteurs : Andrew M. Mcmillan [Australie] ; Karl B. Landorf [Australie] ; Mark F. Gilheany [Australie] ; Adam R. Bird [Australie] ; Adam D. Morrow [Australie] ; Hylton B. Menz

Source :

RBID : ISTEX:DF77D7DCF72FA7F1D14CA8DB3F496F1BC5B70D65

Abstract

Objective To investigate the effectiveness of ultrasound guided corticosteroid injection in the treatment of plantar fasciitis. Design Randomised, investigator and participant blinded, placebo controlled trial. Setting University clinic in Melbourne, Australia. Participants 82 people with a clinical and ultrasound diagnosis of plantar fasciitis unrelated to systemic inflammatory disease. Interventions Participants were randomly allocated to ultrasound guided injection of the plantar fascia with either 1 mL of 4 mg/mL dexamethasone sodium phosphate (experimental group) or 1 mL normal saline (placebo). Before injection the participants were given an ultrasound guided posterior tibial nerve block with 2% lidocaine (lignocaine). Main outcome measures Primary outcomes were pain, as measured by the foot health status questionnaire (0-100 point scale), and plantar fascia thickness, measured by ultrasound at 4, 8, and 12 weeks. Results Reduction in pain at four weeks favoured the dexamethasone group by 10.9 points (95% confidence interval 1.4 to 20.4, P=0.03). Between group differences for pain scores at eight and 12 weeks were not statistically significant. Plantar fascia thickness measured at four weeks favoured the dexamethasone group by −0.35 mm (95% confidence interval −0.67 to −0.03, P=0.03). At eight and 12 weeks, between group differences for plantar fascia thickness also favoured dexamethasone, at −0.39 mm (−0.73 to −0.05, P=0.02) and −0.43 mm (−0.85 to −0.01, P=0.04), respectively. The number needed to treat with dexamethasone for one successful outcome for pain at four weeks was 2.93 (95% confidence interval 2.76 to 3.12). There were no reported adverse events associated with the intervention. Conclusion A single ultrasound guided dexamethasone injection is a safe and effective short term treatment for plantar fasciitis. It provides greater pain relief than placebo at four weeks and reduces abnormal swelling of the plantar fascia for up to three months. However, clinicians offering this treatment should also note that significant pain relief did not continue beyond four weeks. Trial registration Australian New Zealand Clinical Trials Registry ACTRN12610000239066.

Url:
DOI: 10.1136/bmj.e3260


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Ultrasound guided corticosteroid injection for plantar fasciitis: randomised controlled trial</title>
<author>
<name sortKey="Mcmillan, Andrew M" sort="Mcmillan, Andrew M" uniqKey="Mcmillan A" first="Andrew M" last="Mcmillan">Andrew M. Mcmillan</name>
</author>
<author>
<name sortKey="Landorf, Karl B" sort="Landorf, Karl B" uniqKey="Landorf K" first="Karl B" last="Landorf">Karl B. Landorf</name>
</author>
<author>
<name sortKey="Gilheany, Mark F" sort="Gilheany, Mark F" uniqKey="Gilheany M" first="Mark F" last="Gilheany">Mark F. Gilheany</name>
</author>
<author>
<name sortKey="Bird, Adam R" sort="Bird, Adam R" uniqKey="Bird A" first="Adam R" last="Bird">Adam R. Bird</name>
</author>
<author>
<name sortKey="Morrow, Adam D" sort="Morrow, Adam D" uniqKey="Morrow A" first="Adam D" last="Morrow">Adam D. Morrow</name>
</author>
<author>
<name sortKey="Menz, Hylton B" sort="Menz, Hylton B" uniqKey="Menz H" first="Hylton B" last="Menz">Hylton B. Menz</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:DF77D7DCF72FA7F1D14CA8DB3F496F1BC5B70D65</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1136/bmj.e3260</idno>
<idno type="url">https://api.istex.fr/document/DF77D7DCF72FA7F1D14CA8DB3F496F1BC5B70D65/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000D74</idno>
<idno type="wicri:Area/Istex/Curation">000D65</idno>
<idno type="wicri:Area/Istex/Checkpoint">000391</idno>
<idno type="wicri:Area/Main/Merge">000779</idno>
<idno type="wicri:Area/Main/Curation">000778</idno>
<idno type="wicri:Area/Main/Exploration">000778</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Ultrasound guided corticosteroid injection for plantar fasciitis: randomised controlled trial</title>
<author>
<name sortKey="Mcmillan, Andrew M" sort="Mcmillan, Andrew M" uniqKey="Mcmillan A" first="Andrew M" last="Mcmillan">Andrew M. Mcmillan</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Podiatry, Faculty of Health Sciences, La Trobe University, Vic 3086</wicri:regionArea>
<wicri:noRegion>Vic 3086</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Landorf, Karl B" sort="Landorf, Karl B" uniqKey="Landorf K" first="Karl B" last="Landorf">Karl B. Landorf</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Podiatry, Faculty of Health Sciences, La Trobe University, Vic 3086</wicri:regionArea>
<wicri:noRegion>Vic 3086</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gilheany, Mark F" sort="Gilheany, Mark F" uniqKey="Gilheany M" first="Mark F" last="Gilheany">Mark F. Gilheany</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Podiatry, Faculty of Health Sciences, La Trobe University, Vic 3086</wicri:regionArea>
<wicri:noRegion>Vic 3086</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bird, Adam R" sort="Bird, Adam R" uniqKey="Bird A" first="Adam R" last="Bird">Adam R. Bird</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Podiatry, Faculty of Health Sciences, La Trobe University, Vic 3086</wicri:regionArea>
<wicri:noRegion>Vic 3086</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Morrow, Adam D" sort="Morrow, Adam D" uniqKey="Morrow A" first="Adam D" last="Morrow">Adam D. Morrow</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Podiatry, Faculty of Health Sciences, La Trobe University, Vic 3086</wicri:regionArea>
<wicri:noRegion>Vic 3086</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Menz, Hylton B" sort="Menz, Hylton B" uniqKey="Menz H" first="Hylton B" last="Menz">Hylton B. Menz</name>
<affiliation>
<wicri:noCountry code="subField">University</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">BMJ : British Medical Journal</title>
<title level="j" type="abbrev">BMJ</title>
<idno type="eISSN">1756-1833</idno>
<imprint>
<publisher>British Medical Journal Publishing Group</publisher>
<date type="published" when="2012">2012</date>
<biblScope unit="volume">344</biblScope>
</imprint>
</series>
<idno type="istex">DF77D7DCF72FA7F1D14CA8DB3F496F1BC5B70D65</idno>
<idno type="DOI">10.1136/bmj.e3260</idno>
<idno type="href">bmj-344-bmj-e3260.pdf</idno>
<idno type="ArticleID">mcma000881</idno>
<idno type="local">bmj;344/may22_1/e3260</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Objective To investigate the effectiveness of ultrasound guided corticosteroid injection in the treatment of plantar fasciitis. Design Randomised, investigator and participant blinded, placebo controlled trial. Setting University clinic in Melbourne, Australia. Participants 82 people with a clinical and ultrasound diagnosis of plantar fasciitis unrelated to systemic inflammatory disease. Interventions Participants were randomly allocated to ultrasound guided injection of the plantar fascia with either 1 mL of 4 mg/mL dexamethasone sodium phosphate (experimental group) or 1 mL normal saline (placebo). Before injection the participants were given an ultrasound guided posterior tibial nerve block with 2% lidocaine (lignocaine). Main outcome measures Primary outcomes were pain, as measured by the foot health status questionnaire (0-100 point scale), and plantar fascia thickness, measured by ultrasound at 4, 8, and 12 weeks. Results Reduction in pain at four weeks favoured the dexamethasone group by 10.9 points (95% confidence interval 1.4 to 20.4, P=0.03). Between group differences for pain scores at eight and 12 weeks were not statistically significant. Plantar fascia thickness measured at four weeks favoured the dexamethasone group by −0.35 mm (95% confidence interval −0.67 to −0.03, P=0.03). At eight and 12 weeks, between group differences for plantar fascia thickness also favoured dexamethasone, at −0.39 mm (−0.73 to −0.05, P=0.02) and −0.43 mm (−0.85 to −0.01, P=0.04), respectively. The number needed to treat with dexamethasone for one successful outcome for pain at four weeks was 2.93 (95% confidence interval 2.76 to 3.12). There were no reported adverse events associated with the intervention. Conclusion A single ultrasound guided dexamethasone injection is a safe and effective short term treatment for plantar fasciitis. It provides greater pain relief than placebo at four weeks and reduces abnormal swelling of the plantar fascia for up to three months. However, clinicians offering this treatment should also note that significant pain relief did not continue beyond four weeks. Trial registration Australian New Zealand Clinical Trials Registry ACTRN12610000239066.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Menz, Hylton B" sort="Menz, Hylton B" uniqKey="Menz H" first="Hylton B" last="Menz">Hylton B. Menz</name>
</noCountry>
<country name="Australie">
<noRegion>
<name sortKey="Mcmillan, Andrew M" sort="Mcmillan, Andrew M" uniqKey="Mcmillan A" first="Andrew M" last="Mcmillan">Andrew M. Mcmillan</name>
</noRegion>
<name sortKey="Bird, Adam R" sort="Bird, Adam R" uniqKey="Bird A" first="Adam R" last="Bird">Adam R. Bird</name>
<name sortKey="Gilheany, Mark F" sort="Gilheany, Mark F" uniqKey="Gilheany M" first="Mark F" last="Gilheany">Mark F. Gilheany</name>
<name sortKey="Landorf, Karl B" sort="Landorf, Karl B" uniqKey="Landorf K" first="Karl B" last="Landorf">Karl B. Landorf</name>
<name sortKey="Mcmillan, Andrew M" sort="Mcmillan, Andrew M" uniqKey="Mcmillan A" first="Andrew M" last="Mcmillan">Andrew M. Mcmillan</name>
<name sortKey="Morrow, Adam D" sort="Morrow, Adam D" uniqKey="Morrow A" first="Adam D" last="Morrow">Adam D. Morrow</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Belgique/explor/OpenAccessBelV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000778 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000778 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Belgique
   |area=    OpenAccessBelV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:DF77D7DCF72FA7F1D14CA8DB3F496F1BC5B70D65
   |texte=   Ultrasound guided corticosteroid injection for plantar fasciitis: randomised controlled trial
}}

Wicri

This area was generated with Dilib version V0.6.25.
Data generation: Thu Dec 1 00:43:49 2016. Site generation: Wed Mar 6 14:51:30 2024